BD (NYSE:BDX) today announced the commercial launch of its CentroVena One insertion system, a central venous catheter (CVC) insertion device. Franklin Lakes, New Jersey-based BD says it's the first all-in-one CVC insertion device on the market. It designed the device to simplify central line placement for clinicians and enhance patient safety. … [Read more...] about BD launches new central venous catheter insertion device
Catheters
Pulse Biosciences has positive PFA data at HRS 2026
Pulse Biosciences (Nasdaq:PLSE) today announced new positive clinical findings for its nPulse cardiac catheter system. nPulse uses proprietary nanosecond pulsed field ablation (nsPFA) energy to deliver a complete circumferential lesion in a single, brief energy application without the need to stack lesions. It also eliminates the need to stop, … [Read more...] about Pulse Biosciences has positive PFA data at HRS 2026
Medtronic wins FDA breakthrough nod for Sphere-9 catheter, reports new clinical milestones for Affera
Medtronic (NYSE:MDT) today announced new milestones for its Affera family of technologies, including FDA breakthrough device designation. The medtech giant said the FDA granted breakthrough device designation for its Sphere-9 catheter for the treatment of ventricular tachycardia (VT). At Heart Rhythm Society (HRS) 2026 in Chicago, the company … [Read more...] about Medtronic wins FDA breakthrough nod for Sphere-9 catheter, reports new clinical milestones for Affera
Boston Scientific studies back Farawave, Faraflex, Watchman FLX Pro and more
Boston Scientific (NYSE:BSX) today shared new clinical findings supporting its wide-ranging electrophysiology (EP) portfolio. The Marlborough, Massachusetts-based company shared its findings, covering pulsed field ablation (PFA) and combined approaches with left atrial appendage closure (LAAC) to treat AFib, reduce stroke risk and support … [Read more...] about Boston Scientific studies back Farawave, Faraflex, Watchman FLX Pro and more
Abbott data at HRS 2026 backs PFA, pacing systems
Abbott (NYSE:ABT) today shared new study findings supporting its pulsed field ablation (PFA) and conduction system pacing (CSP) systems. At Heart Rhythm Society (HRS) 2026 in Chicago, the company shared data from four trials backing the portfolios. Findings included six-month data from the FlexPulse IDE study evaluating the TactiFlex … [Read more...] about Abbott data at HRS 2026 backs PFA, pacing systems
AngioDynamics alleges patent infringement by E2 over clot removal technology
AngioDynamics has filed a lawsuit against Endovascular Engineering (E2) in the U.S. District Court for the District of Delaware. Latham, New York-based AngioDynamics alleges that E2 infringes on patents for its AngioVac and AlphaVac blood clot removal systems. AngioVac and AlphaVac, two FDA-approved thrombectomy systems, work to remove blood … [Read more...] about AngioDynamics alleges patent infringement by E2 over clot removal technology
Johnson & Johnson to acquire AtraVerse Medical and its transseptal access system
Johnson & Johnson (NYSE:JNJ) announced today that it entered into a definitive agreement to acquire Atraverse Medical. Atraverse develops the Hotwire transseptal access system, a novel radiofrequency guidewire left-heart access device. It enables zero-exchange left-heart access while acting as a rail for catheter-based therapy systems. … [Read more...] about Johnson & Johnson to acquire AtraVerse Medical and its transseptal access system
Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse
Johnson & Johnson (NYSE:JNJ) today announced the initiation of a new trial evaluating competitive pulsed field ablation (PFA) technologies. The PERSIGMA RCT pits the company's Varipulse Pro PFA platform against the Boston Scientific Farapulse system. It compares the two leading PFA therapies in treating persistent AFib. Varipulse Pro, which … [Read more...] about Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse
Reflow Medical launches next-gen microcatheters
Reflow Medical announced that it launched its next-generation Cora Flex and Cora Force torqueable microcatheters in the U.S. San Clemente, California-based Reflow designed the new microcatheters for complex coronary interventions. They introduce enhancements focused on spinning freedom and torque transmission. The company said this supports … [Read more...] about Reflow Medical launches next-gen microcatheters
Philips launches new Bridge Plus occlusion balloon
Philips (NYSE:PHG) announced today that it launched its next-generation Bridge Plus occlusion balloon system. Amsterdam-based Philips designed Bridge Plus to help electrophysiology (EP) teams rapidly control bleeding and stabilize patients during rare but life-threatening superior vena cava (SVC) tears in transvenous lead extraction (TLE) … [Read more...] about Philips launches new Bridge Plus occlusion balloon
